Nearly one-third of Indians, or about 40 crore people, suffer from lifestyle-related diseases like hypertension, diabetes, heart ailment and they spend a whopping Rs 14 lakh crore on medical treatment, said the International Working President of VHP.
Addressing the press conference here, Togadia, who is also a cancer surgeon but is known more for for his fiery speeches, declined to answer queries related to politics or on the Modi government.
"For the past three years I am concentrating on medical research on issues like de-addiction and affordable treatment for lifestyle diseases through my India Healthline Mission," said the oncologist.
He is here to attend a two-day meeting of the VHP that began today at Reshimbagh Grounds.
Togadia claimed as per WHO and London School of Economics reports, 40 crore Indians, or one third of the population, suffer from lifestyle-related diseases like hypertension, diabetes, heart ailment.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
